Concentrix Corporation (CNXC)
Return on equity (ROE)
| Nov 30, 2024 | Nov 30, 2023 | Nov 30, 2022 | Nov 30, 2021 | Nov 30, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 251,217 | 313,842 | 435,049 | 405,577 | 164,811 |
| Total stockholders’ equity | US$ in thousands | 4,039,720 | 4,143,290 | 2,695,900 | 2,620,260 | 2,302,080 |
| ROE | 6.22% | 7.57% | 16.14% | 15.48% | 7.16% |
November 30, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $251,217K ÷ $4,039,720K
= 6.22%
Concentrix Corporation's return on equity (ROE) has shown fluctuations over the past five years. In November 2020, the ROE was recorded at 7.16%, indicating a moderate profitability relative to shareholders' equity. Subsequently, there was a significant improvement in ROE to 15.48% in November 2021, suggesting enhanced profitability and efficiency in utilizing equity to generate profit.
The upward trend continued in the following year, with ROE reaching 16.14% in November 2022, reflecting a continued positive performance in generating returns for shareholders. However, in November 2023, there was a decline in ROE to 7.57%, indicating a decrease in profitability compared to the previous year.
The downward trend persisted in November 2024, with ROE further decreasing to 6.22%. This decline suggests a potential decrease in the company's ability to generate profits from shareholders' equity, which may raise concerns about the company's efficiency in utilizing its resources effectively.
Overall, Concentrix Corporation's ROE performance has been relatively volatile, with periods of improvement followed by declines. It is crucial for the company to assess the factors contributing to these fluctuations and take strategic actions to enhance ROE and ensure sustainable profitability in the future.
Peer comparison
Nov 30, 2024